171 related articles for article (PubMed ID: 25716425)
1. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
[TBL] [Abstract][Full Text] [Related]
2. A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.
Campayo M; Navarro A; Viñolas N; Tejero R; Muñoz C; Diaz T; Marrades R; Cabanas ML; Gimferrer JM; Gascon P; Ramirez J; Monzo M
PLoS One; 2011; 6(7):e22509. PubMed ID: 21799879
[TBL] [Abstract][Full Text] [Related]
3. A Polymorphism at the microRNA Binding Site in the 3' Untranslated Region of
Sha Z; Lai R; Zhang X; Zhao Y; Wu J; Geng C; Guo Z
DNA Cell Biol; 2020 Oct; 39(10):1886-1894. PubMed ID: 32678982
[TBL] [Abstract][Full Text] [Related]
4. A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma.
Xie Y; Diao L; Zhang L; Liu C; Xu Z; Liu S
Gene; 2014 Apr; 539(2):198-202. PubMed ID: 24530479
[TBL] [Abstract][Full Text] [Related]
5. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
de Larrea CF; Navarro A; Tejero R; Tovar N; Díaz T; Cibeira MT; Rosiñol L; Ferrer G; Rovira M; Rozman M; Monzó M; Bladé J
Clin Cancer Res; 2012 Jul; 18(13):3697-704. PubMed ID: 22539802
[TBL] [Abstract][Full Text] [Related]
6. KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC.
Robles AI; Ryan BM
Ann Oncol; 2016 Feb; 27(2):360-1. PubMed ID: 26578733
[No Abstract] [Full Text] [Related]
7. Reply to the letter to the editor 'KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC' by Robles et al.
Lee SY; Choi JE; Park JY
Ann Oncol; 2016 Feb; 27(2):361-3. PubMed ID: 26578724
[No Abstract] [Full Text] [Related]
8. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
[TBL] [Abstract][Full Text] [Related]
10. Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.
Yang Y; Gao W; Ding X; Xu W; Liu D; Su B; Sun Y
Oncotarget; 2017 Mar; 8(10):16313-16324. PubMed ID: 27462918
[TBL] [Abstract][Full Text] [Related]
11. A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
Hong MJ; Lee SY; Choi JE; Jin CC; Kang HJ; Baek SA; Lee SY; Shin KM; Jeong JY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Son JW; Park JY
Oncotarget; 2016 Mar; 7(13):15948-58. PubMed ID: 26893365
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of miRNA sequences and non-small cell lung cancer survival.
Hu Z; Chen J; Tian T; Zhou X; Gu H; Xu L; Zeng Y; Miao R; Jin G; Ma H; Chen Y; Shen H
J Clin Invest; 2008 Jul; 118(7):2600-8. PubMed ID: 18521189
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.
Xu J; Yin Z; Gao W; Liu L; Yin Y; Liu P; Shu Y
PLoS One; 2013; 8(10):e77024. PubMed ID: 24146953
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
17. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
18. BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
Jiang BY; Zhang XC; Su J; Meng W; Yang XN; Yang JJ; Zhou Q; Chen ZY; Chen ZH; Xie Z; Chen SL; Wu YL
Mol Cancer; 2013 Jun; 12():61. PubMed ID: 23758992
[TBL] [Abstract][Full Text] [Related]
19. miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
Xie C; Han Y; Liu Y; Han L; Liu J
Int J Clin Exp Pathol; 2014; 7(10):6534-42. PubMed ID: 25400731
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.
Wu S; Shen W; Yang L; Zhu M; Zhang M; Zong F; Geng L; Wang Y; Huang T; Pan Y; Cao S; Dai J; Ma H; Wu J
Cancer Med; 2019 May; 8(5):2636-2645. PubMed ID: 30843663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
